PTC Therapeutics (PTCT) announced that the FDA accelerated approval of its gene therapy for the treatment of AADC deficiency, the first-ever ...

In a report released today, Jason Celino from KeyBanc maintained a Buy rating on PTC (PTC – Research Report). The company’s shares ...

Industrial software maker PTC forecast first-quarter revenue below estimates on Wednesday, signaling continued weakness in ...

Nov 13 (Reuters) - The U.S. Food and Drug Administration approved PTC Therapeutics' (PTCT.O), opens new tab gene therapy to ...

PTC Industries stock surged 278% in two years, boosted by strong financials and significant orders, including one from Israel ...

BOSTON (AP) — BOSTON (AP) — PTC Inc. (PTC) on Wednesday reported fiscal fourth-quarter earnings of $126.5 million. The Boston-based company said it had net income of $1.04 per share. Earnings, ...

the global leader in Configuration Lifecycle Management (CLM), today announced a strategic partnership and joint go-to-market strategy with PTC, a global software company that provides solutions ...

The biopharmaceutical company posted revenue of $196.8 million in the period, also beating Street forecasts. Five analysts surveyed by Zacks expected $173.5 million. PTC Therapeutics expects full-year ...

Analysts expect PTC to post earnings of $1.43 per share for the quarter. Individual interested in participating in the company’s earnings conference call can do so using this link. PTC (NASDAQ ...

PTC Inc. (PTC) came out with quarterly earnings of $1.54 per share, beating the Zacks Consensus Estimate of $1.43 per share. This compares to earnings of $1.20 per share a year ago. These figures are ...

Engineering and design software provider PTC (NASDAQ:PTC ... 3D tours or interactive movies. Reviewing a company’s long-term performance can reveal insights into its business quality.